




SObjective: This study was undertaken to investigate the potential role of Irbesartan in
amelioration of myocardial I/R injury induced by ligation of coronary artery in a rat
model.
Materials & Methods: Adult male Swiss Albino rats were randomized into 4 equal
groups. Group (1) sham group: rats underwent the same anesthetic and surgical
procedure as the control group except ligation of LAD coronary artery, Group (2)
control group: rats subjected to regional ischemia for 25 min and reperfusion for 2 hours
by ligation of LAD coronary artery, Group (3) control vehicle group: rats received
vehicle of Irbesartan (normal saline) via I.P injection and subjected to regional ischemia
for 25 min and reperfusion for 2 hours by ligation of LAD coronary artery, Group (4)
Irbesartan treated group:rats pretreated with Irbesartan 3mg/kg i.p. 30 minutes before
ligation of LAD coronary artery. At the end of experiment (2 hr of reperfusion), blood
samples were collected from the heart for measurement of plasma level of cardiac
troponin I(cTn I). after that the heart was harvested and divided in to 3 parts, one part
was used for measurement of SSDNA (a marker for apoptosis) and another part was
homogenized for the measurement of tissue tumor necrosis factor-a (TNF-a) and
interleukin-1b (IL-1b) and interleukin-6,Monocyte chemo attractant protein-1 and
Macrophage inﬂammatory protein -1a and the last part for histopathology study.
Results: Compared with the sham group, levels of myocardial TNF-a & IL-1b, IL-6,
MCP-1. MIP-1alpha; plasma cTn I were increased (p<0.05). Histologically,all rats in
control group showed signiﬁcant (p<0.05) cardiac injury. Furthermore all rats in
control group showed signiﬁcant (p<0.05) apoptosis. Irbesartan signiﬁcantly coun-
teract the increase in myocardium level of TNF-a, IL-1B, IL-6, MCP-1, MIP-1alpha,
plasma cTnI& SSDNA apoptotic marker (p<0.05). Histological analysis revealed that
Irbesartan markedly reduced (p<0.05) the severity of heart injury in the rats under-
went LAD ligation procedure.
Conclusion: The results of the present study reveal that Irbesartan may ameliorate
myocardial I/R injury in rats via interfering with inﬂammatory reactions & apoptosis
which induced by I/R injury.
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Background: The importance of doxorubicin, as a potent antitumor antibiotic, is
limited by the development of life-threatening cardiomyopathy.. It has been shown
that free radicals are involved in doxorubicin-induced toxicity. Doxorubicin causes the
generation of free radicals and the induction of oxidative stress, associated with
cellular injury. Phenolic compounds are a chemical family whose members have one
or more hydroxyl groups attached directly to an aromatic ring. phenolic compounds
can frequently act as free-radical scavengers.
Objective: This study was undertaken to investigate the cardioprotective potential of
some phenolic compounds namely caffeic acid, ferulic acid and syringic acid in
doxorubicin induced cardiotoxicity.
Materials-Methods: The rats were randomized into 5 equal groups each of six. Group
1 sham group, which received no treatment, group 2, received doxorubicin at a dose
3 mg/kg IP every other 2 days plus normal saline as vehicle orally and considered as
Cardiotoxic Control, Group 3 received doxorubicin plus ferulic acid 10 mg/day p.o for
2 weeks, group 4 received doxorubicin plus caffeic acid 40 mg/day p.o for 2 weeks,
group 5 received doxorubicin plus syringic acid 100 mg/day p.o for 2 weeks. Left
venrricular function was measured by volume ﬂow meter.
At the end of experiment and after recording the ﬁnal body weight, blood samples
were collected from the heart for measurement of plasma level of cardiac troponin I
(cTn I) and serum level of oxidative stress parameter malondialdehyde (MDA) and
also for measurement of high sensitive c-reactive protein (hs-CRP). The heart were
weighted and then harvested. The apical side was ﬁxed in 10% formalin for histo-
logical examination and the basal side was homogenized for the measurement of
tissue tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) and interleukin-10
(IL-10).
Results: Compared with sham group, levels of myocardial TNF-a, IL-1band IL-10;
plasma cTnI were signiﬁcantly increased (p<0.001) in Doxorubicin treated group
with signiﬁcant increase (p<0.001) in MDA, hs-CRP and signiﬁcant impairment of left
ventricular ejection fraction and cardiac out put (p<0.001). Caffeic acid, ferulic acid and
syringic acid signiﬁcantly counteracted the increase in myocardial TNF-alfa,IL-1-beta,
IL-10, serum cTnI, hs-CRP and MDA. Additionally these compounds signiﬁcantly
(p,0.001) counteracted the decrease in ejection fraction and cardiac out put.
Conclusions: The results of the present study reveal that phenolic compounds (caffeic
acid,ferulic acid and syringic acid have been shown to decrease doxorubicin-induced
cardiotoxicity via interfering with inﬂammatory reactions and also prophylactic use of
these compounds may ameliorate the left ventricular function which deteriorate by
doxorubicin administration.
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Background: Ischaemia /reperfusion induce myocyte necrosis and apoptosis that
seem to be the prevalent mode of death during the ischemic period and the subsequentJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAreperfusion. L-carnitine is essential for the transport and metabolism of fatty acids to
the mitochondria for energy production.
Aim of the study: We aimed to study the possible cardio protective potential of
L-carnitine in myocardial regional ischemia – reperfusion injury.
Materials-Methods: Dwale-sprague rats were divided into ﬁve groups (6 rats for
each) assigned as I, II, III, IV, V. Group I (sham), rats were subjected for all surgical
procedure without ligation of (LAD). GroupII (control), rats were subjected for entire
surgical procedure with ligation of (LAD). GroupIII (control vehicle), rats pretreated
with normal saline (vehicle for L-carnitine) for 7days then subjected for entire surgical
procedure with ligation of (LAD). Group (L-carnitine treated group), rats previously
treated with (100 mg/kg, IP) L-carnitine then subjected to entire surgical procedure
including LAD ligation for 25 minutes followed by 120 minutes reperfusion. At the
end of reperfusion,cardiac tissue TNF-a, IL-1b, IL-6 and ssDNA as well as plasma
cardiac troponin I (cTnI) were measured.It has been found that L-carnitine treated
group showed signiﬁcant reduction (r<0.05) in TNFa, IL-1b, IL-6, ssDNA (a marker
of apoptosis) and cTnI with respect to the control or control vehicle groups. Addi-
tionally histopathological study revealed that L-carnitine signiﬁcantly (r<0.05)
improved cardiac injury score as compared with control group. It is concluded from
this study that L-carnitine reduce inﬂammatory reaction associated with ischemia/
reperfusion and ameliorates apoptosis.
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Ischemia reperfusion and apoptosis both are serious complications of myocardial
ischemia. Although the restoration of blood ﬂow to an ischemic organ is essential to
prevent irreversible tissue injury, reperfusion may augment's tissue injury in excess of
that produced by ischemia alone. Restoration of blood ﬂow to ischemic myocardium
results in the ischemia reperfusion (I/R) injury.This study was undertaken to inves-
tigate the cardioprotective potential of goserline acetate in regional ischemia reper-
fusion and apoptosis of the male rat hearts.
Material-Method: Eighteen Swiss albino rats were randomized into 3 equal groups(6
in each group). Group 1 sham group, rat underwent the same anesthetic and surgical
procedure as the control group except for surgical ligation of LAD, Group 2 control
group, rats underwent surgical ligation of LAD and subjected to regional ischemia
for 25 min and reperfusion for 40 min, Group 3 Goserelin acetate treated, rats
underwent abdominal subcutaneous injection of Goserelin (LHRH analogue) 3wks
before the surgery, then underwent surgical LAD ligation, and subjected to 25min
of ischemia and 40min of reperfusion.At the end of experiment blood samples
were collected from the heart for measurement of plasma level of cardiac troponin
I(cTn I). The heart were harvested, and divided into 3 sections, the 1st for the
measurement of cardiac apoptosis level, the 2nd homogenized for measurement of
tissue (TNF-a,IL1-b,ICAM-1) and the 3rd was ﬁxed in 10% formalin for histological
examination.
Result: Compared with the sham group, levels of myocardial TNF-a& IL-1b, ICAM-1
and apoptosis; plasma cTn I were increased (p<0.05) in control group. Histologically,
all control group rats showed signiﬁcant myocardial injury (p<0.05) compared with
sham group. Goserelin signiﬁcantly counteract the increase in myocardial level of TNF-
a, IL-1, ICAM-1, plasma cTn I and apoptosis (p<0.05). Histological analysis revealed
that Goserelin markedly reduced (p<0.05) the severity of heart injury in the rats
underwent the regional ischemia- reperfusion procedure.
Conclusion: Goserelin acetate may ameliorate regional I/R injury and apoptosis in the
ischemic heart in rats via interfering with inﬂammatory pathways.Congestive Heart Failure
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Purpose: We aimed to investigate the role of intraventricular dyssynchrony using
echocardiography in predicting response to levosimendan therapy in patients with
acute systolic heart failure.
Methods: Patients with an ejection fraction (EF) lower than 35% who required
intravenous inotropic support despite optimal heart failure therapy were included to
this study. Regional myocardial function was evaluated in eight segments (basal and
middle segments of intraventricular septum, lateral, anterior, inferior walls) by tissue
doppler imaging. Peak systolic velocities were measured for each segment. IntervalLS C59
